BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9569197)

  • 1. Monoclonal antibody-based immunoassays for the specific quantitation of rat PAI-1 antigen and activity in biological samples.
    Ngo TH; Verheyen S; Knockaert I; Declerck PJ
    Thromb Haemost; 1998 Apr; 79(4):808-12. PubMed ID: 9569197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoassays for the quantitation of porcine PAI-1 antigen and activity in biological fluid samples.
    Leng HM; Brouwers E; Knockaert I; Declerck PJ
    Thromb Haemost; 2000 Dec; 84(6):1082-6. PubMed ID: 11154117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological quantitation of rabbit plasminogen activator inhibitor-1 in biological samples: evidence that rabbit platelets do not contain PAI-1.
    Ngo TH; Declerck PJ
    Thromb Haemost; 1999 Nov; 82(5):1510-5. PubMed ID: 10595646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice.
    Declerck PJ; Verstreken M; Collen D
    Thromb Haemost; 1995 Nov; 74(5):1305-9. PubMed ID: 8607114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of recombinant rat plasminogen activator inhibitor-1 and development of immunological tools for its quantitation.
    Ngo TH; Verheyen S; Knockaert I; Declerck PJ
    J Pharm Belg; 1997; 52(4):165-6. PubMed ID: 9316343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter evaluation of commercially available methods for the immunological determination of plasminogen activator inhibitor-1 (PAI-1).
    Declerck PJ; Moreau H; Jespersen J; Gram J; Kluft C
    Thromb Haemost; 1993 Nov; 70(5):858-63. PubMed ID: 8128446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and characterization of recombinant porcine plasminogen activator inhibitor-1.
    Bijnens AP; Knockaert I; Cousin E; Kruithof EK; Declerck PJ
    Thromb Haemost; 1997 Feb; 77(2):350-6. PubMed ID: 9157595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization and application of monoclonal antibodies against PAI-1.
    Ding H; Wu X; Zhou X; Zhu Y; Song H
    Chin J Biotechnol; 1994; 10(2):121-8. PubMed ID: 7803688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay.
    Declerck PJ; Alessi MC; Verstreken M; Kruithof EK; Juhan-Vague I; Collen D
    Blood; 1988 Jan; 71(1):220-5. PubMed ID: 3257145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA.
    Holvoet P; Cleemput H; Collen D
    Thromb Haemost; 1985 Oct; 54(3):684-7. PubMed ID: 3937265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes. Biochemical and multicenter validation of a two site immunosorbent assay.
    Rånby M; Nguyen G; Scarabin PY; Samama M
    Thromb Haemost; 1989 Jun; 61(3):409-14. PubMed ID: 2508254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive measurement of thrombopoietin by a monoclonal antibody based sandwich enzyme-linked immunosorbent assay.
    Folman CC; von dem Borne AE; Rensink IH; Gerritsen W; van der Schoot CE; de Haas M; Aarden L
    Thromb Haemost; 1997 Oct; 78(4):1262-7. PubMed ID: 9364995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-linked immunosorbent assay of total inhibin: direct determination based on inhibin alpha subunit-specific monoclonal antibodies.
    Khosravi J; Krishna RG; Khaja N; Bodani U; Diamandi A
    Clin Biochem; 2004 May; 37(5):370-6. PubMed ID: 15087252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
    Welfringer F; d'Athis P; Scherrmann JM; Hervé F
    J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S35225 is a direct inhibitor of Plasminogen Activator Inhibitor type-1 activity in the blood.
    Rupin A; Gaertner R; Mennecier P; Richard I; Benoist A; De Nanteuil G; Verbeuren TJ
    Thromb Res; 2008; 122(2):265-70. PubMed ID: 18177924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
    Grebenchtchikov N; Maguire TM; Riisbro R; Geurts-Moespot A; O'Donovan N; Schmitt M; McGreal G; McDermott E; O'Higgins N; Brünner N; Sweep CG; Duffy MJ
    Oncol Rep; 2005 Jul; 14(1):235-9. PubMed ID: 15944795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorothioate oligodeoxyribonucleotides antisense to PAI-1 mRNA increase fibrinolysis and modify experimental thrombosis in rats.
    Pawlowska Z; Pluskota E; Chabielska E; Buczko W; Okruszek A; Stec WJ; Cierniewski CS
    Thromb Haemost; 1998 Feb; 79(2):348-53. PubMed ID: 9493589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidation of the binding regions of PAI-1 neutralizing antibodies using chimeric variants of human and rat PAI-1.
    Bijnens AP; Ngo TH; Gils A; Dewaele J; Knockaert I; Stassen JM; Declerck PJ
    Thromb Haemost; 2001 May; 85(5):866-74. PubMed ID: 11372681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients.
    de Witte JH; Sweep CG; Klijn JG; Grebenschikov N; Peters HA; Look MP; van Tienoven TH; Heuvel JJ; van Putten WL; Benraad TJ; Foekens JA
    Br J Cancer; 1999 Mar; 79(7-8):1190-8. PubMed ID: 10098758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.